Louisiana Anesthesia Group

Hemodynamic Effects of Propofol

Disclaimer: This article is intended solely for informational and educational purposes only. It does not constitute medical advice.

Valued for its rapid onset and favorable recovery profile, propofol is one of the most widely used intravenous agents for sedation and general anesthesia (de Wit et al., 2016). Propofol is considered to produce more desirable hemodynamic effects than several other agents. However, its potential to result in hypotension represents a significant clinical consideration across sedation and anesthetic settings. 

The mechanism underlying propofol-induced hypotension has received significant research attention. Ebert (2005) demonstrated that even at sedative (non-general anesthetic) doses, propofol substantially inhibits muscle sympathetic nerve activity (SNA) in healthy volunteers, with SNA reduced by 65% at moderate sedation and 92% at deep sedation. This sympathoinhibition was accompanied by decreases in plasma norepinephrine (18% and 44%, respectively) and reductions in mean arterial pressure of 9% and 18% at moderate and deep sedation.

Notably, propofol also blunted the baroreflex response to hypotensive challenge, impairing the compensatory increase in SNA that would normally buffer a falling blood pressure, though the reflex heart rate response remained intact. These findings indicate that propofol’s hypotensive effect reflects a combined disruption of basal sympathetic outflow and reflex sympathetic control. 

Other research regarding general anesthesia maintenance found that increasing propofol concentrations produced significant decreases in mean systemic filling pressure, venous resistance, and arterial resistance, yet cardiac output remained unchanged. This suggests that propofol’s hypotensive effect during maintenance anesthesia is primarily attributable to a reduction in stressed vascular volume and venodilation rather than myocardial depression, a finding with direct implications for fluid management, as hypovolemic patients may experience more pronounced blood pressure decreases. 

Age appears to modulate the hemodynamic effects of propofol. Compared to thiopental, propofol has a smaller impact on hemodynamics in elderly patients in elderly patients undergoing hip replacement surgery. Slow, continuous propofol infusion (1.6 mg/kg) produced a modest mean decline in systolic blood pressure (8.3% ± 5.5%), comparable to thiopental, and better attenuated the hemodynamic response to laryngoscopy and intubation. However, myocardial ischemia was detected in 23% of patients overall, independent of hemodynamic changes or anesthetic type, suggesting no positive impact on ischemic risk in older or cardiovascularly compromised patients. 

In pediatric sedation, Koroglu et al. (2006) compared propofol with dexmedetomidine in children undergoing MRI and found that propofol produced significantly greater reductions in mean arterial pressure and respiratory rate, along with oxygen desaturation in four children, despite faster onset, recovery, and discharge times. This finding supports the usefulness of propofol’s hemodynamic effects in pediatric care as well. Additionally, the research highlights the need for heightened awareness when respiratory and cardiovascular monitoring capacity is limited, such as in some non-operating room anesthesia settings. 

Hypotension is arguably the most consequential of the hemodynamic effects produced by propofol. It is attributed to sympathetic inhibition, impaired baroreflex responsiveness, and reduced venous and arterial resistance. Clinicians administering propofol, particularly in non-anesthesia settings, older adults, or pediatric patients, should anticipate these effects, ensure adequate volume status, and maintain vigilant hemodynamic monitoring throughout sedation or anesthesia. 

References 

  1. Chan, V. W. S., & Chung, F. F. (1996). Propofol infusion for induction and maintenance of anesthesia in elderly patients: Recovery and hemodynamic profiles. Journal of Clinical Anesthesia, 8(4), 317–323. https://doi.org/10.1016/0952-8180(96)00041-4 
  2. de Wit, F., van Vliet, A. L., de Wilde, R. B., Jansen, J. R., Vuyk, J., Aarts, L. P., de Jonge, E., Veelo, D. P., & Geerts, B. F. (2016). The effect of propofol on haemodynamics: Cardiac output, venous return, mean systemic filling pressure, and vascular resistances. British Journal of Anaesthesia, 116(6), 784–789. https://doi.org/10.1093/bja/aew126 
  3. Ebert, T. J. (2005). Sympathetic and hemodynamic effects of moderate and deep sedation with propofol in humans. Anesthesiology, 103(1), 20–24. https://doi.org/10.1097/00000542-200507000-00007 
  4. Koroglu, A., Teksan, H., Sagır, O., Yucel, A., Toprak, H. I., & Ersoy, O. M. (2006). A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging. Anesthesia & Analgesia, 103(1), 63–67. https://doi.org/10.1213/01.ANE.0000219592.82598.AA